Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Multiple Myeloma 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Lymphoid 1Leukemia 1Kidney Neoplasms 1Hodgkin Disease 1Breast Neoplasms 1

Interventions

Filgrastim 5fludarabine phosphate 4Cyclophosphamide 4Antilymphocyte Serum 4Mycophenolic Acid 3Carboplatin 3pembrolizumab 2Tacrolimus 2Sirolimus 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2Methotrexate 2Drug Therapy 2Cyclosporine 2Busulfan 2valspodar 1tremelimumab 1thymoglobulin 1temsirolimus 1tanespimycin 1sargramostim 1poly ICLC 1liposomal doxorubicin 1ixabepilone 1interferon-alfa-1b 1glutamic acid diethyl ester 1fludarabine 1etoposide phosphate 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Social Determinants of Health × Lymphoid × Clear all
NCT05871008 2025-09-15

Integrated Actionable Aging Assessment for Cancer Patients Pilot

University of Colorado, Denver

Phase NA Active not recruiting
35 enrolled
BreastGenitourinaryLymphoidOther hematologic neoplasmPlasma cell

Urinary Bladder Neoplasms, Breast Neoplasms, Hodgkin Disease, Kidney Neoplasms, Leukemia, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Multiple Myeloma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡